|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.85 TWD | -3.03% |
|
-7.05% | -27.31% |
| 07-13 | EirGenix Partner Secures EMA Nod for Breast Cancer Biosimilar Vial | MT |
| 05-27 | Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7% | MT |
| Market Cap | 13.58B 420M 366M 338M 311M 588M 40.39B 601M 4.04B 1.59B 19.75B 1.58B 1.54B 68.14B | P/E 2024 |
-31.6x | P/E 2025 | -24.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.76B 363M 317M 293M 270M 509M 34.98B 521M 3.5B 1.38B 17.1B 1.36B 1.33B 59.01B | EV / Sales 2024 |
18.2x | EV / Sales 2025 | 16.8x |
| Free-Float |
60% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.03% | ||
| 1 week | -7.05% | ||
| Current month | -10.12% | ||
| 1 month | -3.44% | ||
| 3 months | -11.36% | ||
| 6 months | -31.84% | ||
| Current year | -27.31% |
| 1 week | 44.75 |  | 50.6 |
| 1 month | 44.75 | | 53.6 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 112 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 31/03/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 02/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 19/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 13/06/2013 |
Ming Hsien Chen
BRD | Director/Board Member | - | 12/09/2016 |
Fu Hsiu Yin
BRD | Director/Board Member | - | 12/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | -7.05% | -32.45% | -57.89% | 419M | |
| -0.33% | +1.83% | +24.73% | -6.86% | 68.85B | |
| +0.67% | +0.93% | +36.86% | +197.49% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| +1.12% | +0.35% | -52.09% | -53.39% | 41.24B | |
| -1.40% | +3.43% | +64.81% | -25.41% | 30.41B | |
| -2.11% | -9.45% | +97.76% | -49.58% | 24.53B | |
| +0.51% | +0.46% | +72.78% | +90.09% | 23.42B | |
| -5.57% | -0.84% | -0.11% | +182.38% | 19.75B | |
| -0.86% | -1.99% | +70.03% | +117.01% | 16.57B | |
| Average | -1.01% | -1.86% | +32.19% | +43.34% | 32.08B | |
| Weighted average by Cap. | -0.34% | -0.08% | +32.47% | +46.70% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.01B 31.17M 27.22M 25.13M 23.12M 43.65M 3B 44.68M 300M 118M 1.47B 117M 114M 5.06B | 1.01B 31.06M 27.12M 25.03M 23.03M 43.49M 2.99B 44.51M 299M 118M 1.46B 117M 114M 5.04B |
| Net income | -698M -21.58M -18.84M -17.39M -16M -30.21M -2.08B -30.92M -208M -81.75M -1.02B -80.99M -79.22M -3.5B | -761M -23.5M -20.52M -18.94M -17.42M -32.9M -2.26B -33.68M -226M -89.04M -1.11B -88.21M -86.27M -3.82B |
| Net Debt | -3.7B -114M -99.71M -92.06M -84.68M -160M -10.99B -164M -1.1B -433M -5.37B -429M -419M -18.54B | -1.82B -56.23M -49.1M -45.33M -41.69M -78.73M -5.41B -80.59M -541M -213M -2.65B -211M -206M -9.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | NT$44.85 | -3.03% | 831,576 |
| 16/07/26 | NT$46.25 | -2.22% | 771,817 |
| 15/07/26 | NT$47.30 | +1.50% | 559,060 |
| 14/07/26 | NT$46.60 | -7.91% | 1,866,362 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
